✦ LIBER ✦

Interferon-α-2a ± ribavirin in hepatitis D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of pegylat

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Comparison of a 6-month course peginterf

✍ S.-D. Lee; M.-L. Yu; P.-N. Cheng; M.-Y. Lai; Y.-C. Chao; S.-J. Hwang; W.-Y. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Long-term clearance of hepatitis C virus

✍ Manns, M. P.; Pockros, P. J.; Norkrans, G.; Smith, C. I.; Morgan, T. R.; Häussin 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Effect of interferon α-ribavirin bithera

✍ Becquemont, Laurent; Chazouilleres, Olivier; Serfaty, Lawrence; Poirier, Jean Ma 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 603 KB

Serum PAI-1 is a novel predictor for res

✍ D. Miki; W. Ohishi; H. Ochi; C. N. Hayes; H. Abe; M. Tsuge; M. Imamura; N. Kamat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Efficacy, safety, and tolerability in pa

✍ Perrillo, Robert P.; Rothstein, Kenneth D.; Alam, Imtiaz; Thuluvath, Paul J.; Pa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB